New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

M. V. Relling, R. M. Krauss, D. M. Roden, T. E. Klein, D. M. Fowler, N. Terada, L. Lin, M. Riel-Mehan, T. P. Do, Michiaki Kubo, S. W. Yee, G. T. Johnson, K. M. Giacomini

Research output: Contribution to journalComment/debate

11 Citations (Scopus)

Abstract

The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

Original languageEnglish
Pages (from-to)897-902
Number of pages6
JournalClinical Pharmacology and Therapeutics
Volume102
Issue number6
DOIs
Publication statusPublished - 01-12-2017

Fingerprint

Precision Medicine
Pharmacogenetics
Research
Community Networks
Translational Medical Research
Genetic Polymorphisms
Research Personnel
Technology
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

Relling, M. V., Krauss, R. M., Roden, D. M., Klein, T. E., Fowler, D. M., Terada, N., ... Giacomini, K. M. (2017). New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine. Clinical Pharmacology and Therapeutics, 102(6), 897-902. https://doi.org/10.1002/cpt.755
Relling, M. V. ; Krauss, R. M. ; Roden, D. M. ; Klein, T. E. ; Fowler, D. M. ; Terada, N. ; Lin, L. ; Riel-Mehan, M. ; Do, T. P. ; Kubo, Michiaki ; Yee, S. W. ; Johnson, G. T. ; Giacomini, K. M. / New Pharmacogenomics Research Network : An Open Community Catalyzing Research and Translation in Precision Medicine. In: Clinical Pharmacology and Therapeutics. 2017 ; Vol. 102, No. 6. pp. 897-902.
@article{eabc9ea48c174d33bed08f11ffe87eb9,
title = "New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine",
abstract = "The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.",
author = "Relling, {M. V.} and Krauss, {R. M.} and Roden, {D. M.} and Klein, {T. E.} and Fowler, {D. M.} and N. Terada and L. Lin and M. Riel-Mehan and Do, {T. P.} and Michiaki Kubo and Yee, {S. W.} and Johnson, {G. T.} and Giacomini, {K. M.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1002/cpt.755",
language = "English",
volume = "102",
pages = "897--902",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "6",

}

Relling, MV, Krauss, RM, Roden, DM, Klein, TE, Fowler, DM, Terada, N, Lin, L, Riel-Mehan, M, Do, TP, Kubo, M, Yee, SW, Johnson, GT & Giacomini, KM 2017, 'New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine', Clinical Pharmacology and Therapeutics, vol. 102, no. 6, pp. 897-902. https://doi.org/10.1002/cpt.755

New Pharmacogenomics Research Network : An Open Community Catalyzing Research and Translation in Precision Medicine. / Relling, M. V.; Krauss, R. M.; Roden, D. M.; Klein, T. E.; Fowler, D. M.; Terada, N.; Lin, L.; Riel-Mehan, M.; Do, T. P.; Kubo, Michiaki; Yee, S. W.; Johnson, G. T.; Giacomini, K. M.

In: Clinical Pharmacology and Therapeutics, Vol. 102, No. 6, 01.12.2017, p. 897-902.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - New Pharmacogenomics Research Network

T2 - An Open Community Catalyzing Research and Translation in Precision Medicine

AU - Relling, M. V.

AU - Krauss, R. M.

AU - Roden, D. M.

AU - Klein, T. E.

AU - Fowler, D. M.

AU - Terada, N.

AU - Lin, L.

AU - Riel-Mehan, M.

AU - Do, T. P.

AU - Kubo, Michiaki

AU - Yee, S. W.

AU - Johnson, G. T.

AU - Giacomini, K. M.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

AB - The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

UR - http://www.scopus.com/inward/record.url?scp=85033374059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033374059&partnerID=8YFLogxK

U2 - 10.1002/cpt.755

DO - 10.1002/cpt.755

M3 - Comment/debate

C2 - 28795399

AN - SCOPUS:85033374059

VL - 102

SP - 897

EP - 902

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -